ID   FDCP-Mix cl.A4
AC   CVCL_2040
SY   FDCP-mix; FDCPmix; FDCP MIX A4; FDPC-mix A4; FDCP mix A4; FDCPmixA4
DR   BTO; BTO_0000446
DR   CLO; CLO_0003074
DR   DSMZ; ACC-401
DR   DSMZCellDive; ACC-401
DR   Lonza; 721
DR   Wikidata; Q54833451
RX   Patent=US5830760;
RX   PubMed=1334022;
RX   PubMed=3091439;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=FDCPmix
CC   Characteristics: IL3 dependent.
CC   Doubling time: ~70-80 hours (DSMZ=ACC-401).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C57BL/6 x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
RX   Patent=US5830760;
RA   Tsai S., Collins S.J.;
RT   "Creating novel hematopoietic cell lines by expressing altered
RT   retinoic acid receptors.";
RL   Patent number US5830760, 03-Nov-1998.
//
RX   PubMed=1334022; DOI=10.1101/gad.6.12a.2258;
RA   Tsai S., Bartelmez S.H., Heyman R., Damm K., Evans R., Collins S.J.;
RT   "A mutated retinoic acid receptor-alpha exhibiting dominant-negative
RT   activity alters the lineage development of a multipotent
RT   hematopoietic cell line.";
RL   Genes Dev. 6:2258-2269(1992).
//
RX   PubMed=3091439; DOI=10.1111/j.1432-0436.1986.tb00391.x;
RA   Spooncer E., Heyworth C.M., Dunn A.R., Dexter T.M.;
RT   "Self-renewal and differentiation of interleukin-3-dependent
RT   multipotent stem cells are modulated by stromal cells and serum
RT   factors.";
RL   Differentiation 31:111-118(1986).
//